Bimoclomol
Identification
- Generic Name
- Bimoclomol
- DrugBank Accession Number
- DB06258
- Background
Bimoclomol is an investigational drug that induces stress proteins and has cytoprotective effects.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 297.781
Monoisotopic: 297.124404606 - Chemical Formula
- C14H20ClN3O2
- Synonyms
- Bimoclomol
- External IDs
- ABT-822
- BRLP-42
Pharmacology
- Indication
Investigated for use/treatment in neuropathy (diabetic) and wounds.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Bimoclomol binds to HSF-1 and induces a prolonged binding of HSF-1 to the respective DNA elements. Since HSF-1 does not bind to DNA in the absence of stress, the bimoclomol-induced extension of HSF-1/DNA interaction may contribute to the chaperone co-induction of bimoclomol observed previously. These findings indicate that bimoclomol may be of value in targeting HSF-1 so as to induce up-regulation of protective Hsp-s in a non-stressful manner and for therapeutic benefit.
Target Actions Organism UHeat shock factor protein 1 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pyridines and derivatives. These are compounds containing a pyridine ring, which is a six-member aromatic heterocycle which consists of one nitrogen atom and five carbon atoms.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pyridines and derivatives
- Sub Class
- Not Available
- Direct Parent
- Pyridines and derivatives
- Alternative Parents
- Piperidines / Heteroaromatic compounds / Trialkylamines / Secondary alcohols / 1,2-aminoalcohols / Azacyclic compounds / Organopnictogen compounds / Organochlorides / Hydrocarbon derivatives
- Substituents
- 1,2-aminoalcohol / Alcohol / Amine / Aromatic heteromonocyclic compound / Azacycle / Heteroaromatic compound / Hydrocarbon derivative / Organic nitrogen compound / Organic oxygen compound / Organochloride
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- 9IYF14814M
- CAS number
- 130493-03-7
- InChI Key
- NMOVJBAGBXIKCG-VKAVYKQESA-N
- InChI
- InChI=1S/C14H20ClN3O2/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18/h4-6,9,13,19H,1-3,7-8,10-11H2/b17-14-
- IUPAC Name
- (Z)-N-[2-hydroxy-3-(piperidin-1-yl)propoxy]pyridine-3-carbonimidoyl chloride
- SMILES
- OC(CO\N=C(/Cl)C1=CN=CC=C1)CN1CCCCC1
References
- General References
- Hargitai J, Lewis H, Boros I, Racz T, Fiser A, Kurucz I, Benjamin I, Vigh L, Penzes Z, Csermely P, Latchman DS: Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun. 2003 Aug 1;307(3):689-95. [Article]
- External Links
- PubChem Compound
- 9576891
- ChemSpider
- 7851332
- ChEMBL
- CHEMBL2104595
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.488 mg/mL ALOGPS logP 1.39 ALOGPS logP 1.57 Chemaxon logS -2.8 ALOGPS pKa (Strongest Acidic) 14 Chemaxon pKa (Strongest Basic) 9.14 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 57.95 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 79.44 m3·mol-1 Chemaxon Polarizability 31.88 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9858 Blood Brain Barrier + 0.9139 Caco-2 permeable - 0.563 P-glycoprotein substrate Substrate 0.5426 P-glycoprotein inhibitor I Inhibitor 0.8807 P-glycoprotein inhibitor II Inhibitor 0.9459 Renal organic cation transporter Inhibitor 0.753 CYP450 2C9 substrate Non-substrate 0.7797 CYP450 2D6 substrate Non-substrate 0.792 CYP450 3A4 substrate Non-substrate 0.5626 CYP450 1A2 substrate Non-inhibitor 0.7449 CYP450 2C9 inhibitor Non-inhibitor 0.8563 CYP450 2D6 inhibitor Non-inhibitor 0.6451 CYP450 2C19 inhibitor Non-inhibitor 0.6087 CYP450 3A4 inhibitor Non-inhibitor 0.8036 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8354 Ames test Non AMES toxic 0.5607 Carcinogenicity Non-carcinogens 0.801 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.5800 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.759 hERG inhibition (predictor II) Inhibitor 0.7706
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0002-9420000000-e98978d10ed7c54f14c2 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0002-0090000000-259ddbd5923546e35f9a Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0002-1390000000-8975b96e322aa6321b2f Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-001l-9540000000-495501b0b6300fb7594e Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-002b-5920000000-7461db73b4003afdb7a0 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9130000000-edc6e9c98262fe26c4cb Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-01si-5920000000-f96df4dbd40c77e4773c Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 168.53322 predictedDeepCCS 1.0 (2019) [M+H]+ 170.89124 predictedDeepCCS 1.0 (2019) [M+Na]+ 176.98439 predictedDeepCCS 1.0 (2019)
Targets
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Transcriptional repressor activity, rna polymerase ii core promoter proximal region sequence-specific binding
- Specific Function
- DNA-binding protein that specifically binds heat shock promoter elements (HSE) and activates transcription. In higher eukaryotes, HSF is unable to bind to the HSE unless the cells are heat shocked.
- Gene Name
- HSF1
- Uniprot ID
- Q00613
- Uniprot Name
- Heat shock factor protein 1
- Molecular Weight
- 57259.87 Da
References
- Hargitai J, Lewis H, Boros I, Racz T, Fiser A, Kurucz I, Benjamin I, Vigh L, Penzes Z, Csermely P, Latchman DS: Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun. 2003 Aug 1;307(3):689-95. [Article]
Drug created at March 19, 2008 16:19 / Updated at February 21, 2021 18:52